WO2008131858A3 - Verwendung acyclisch substituierter furopyrimidin-derivate zur behandlung der pulmonalen arteriellen hypertonie - Google Patents
Verwendung acyclisch substituierter furopyrimidin-derivate zur behandlung der pulmonalen arteriellen hypertonie Download PDFInfo
- Publication number
- WO2008131858A3 WO2008131858A3 PCT/EP2008/003007 EP2008003007W WO2008131858A3 WO 2008131858 A3 WO2008131858 A3 WO 2008131858A3 EP 2008003007 W EP2008003007 W EP 2008003007W WO 2008131858 A3 WO2008131858 A3 WO 2008131858A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pulmonary arterial
- hypertonia
- treating pulmonary
- derivatives
- acyclically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002685128A CA2685128A1 (en) | 2007-04-26 | 2008-04-16 | Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007019691A DE102007019691A1 (de) | 2007-04-26 | 2007-04-26 | Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie |
DE102007019691.3 | 2007-04-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008131858A2 WO2008131858A2 (de) | 2008-11-06 |
WO2008131858A3 true WO2008131858A3 (de) | 2009-07-16 |
Family
ID=39777459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/003007 WO2008131858A2 (de) | 2007-04-26 | 2008-04-16 | Verwendung acyclisch substituierter furopyrimidin-derivate zur behandlung der pulmonalen arteriellen hypertonie |
Country Status (3)
Country | Link |
---|---|
CA (1) | CA2685128A1 (de) |
DE (1) | DE102007019691A1 (de) |
WO (1) | WO2008131858A2 (de) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1817146A1 (de) * | 1968-01-05 | 1969-11-27 | Pfizer & Co C | 4-Aminofuro[2,3-d]pyrimidine und deren Verwendung als Relaxantien fuer glatte Muskeln |
EP1018514A1 (de) * | 1998-07-22 | 2000-07-12 | Suntory Limited | Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten |
WO2000075145A1 (en) * | 1999-06-03 | 2000-12-14 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
EP1132093A1 (de) * | 1999-09-17 | 2001-09-12 | Suntory Limited | Vorbeugungsmittel oder heilmittel gegen myokarditis, dilatierte kardiomyopathie und herzinsuffiziens, die nf-kappa b inhibitoren als aktiven bestandteil enthalten |
WO2002092603A1 (en) * | 2001-05-14 | 2002-11-21 | Novartis Ag | Oxazolo-and furopyrimidines and their use in medicaments against tumors |
WO2003022852A2 (en) * | 2001-09-11 | 2003-03-20 | Smithkline Beecham Corporation | Furo-and thienopyrimidine derivatives as angiogenesis inhibitors |
WO2005092896A1 (en) * | 2004-03-12 | 2005-10-06 | Korea Institute Of Science And Technology | Compound for inhibiting tyrosine kinase activity of ddr2 protein |
WO2005121149A1 (en) * | 2004-06-10 | 2005-12-22 | Xention Discovery Limited | Furanopyrimidine compounds effective as potassium channel inhibitors |
WO2006004658A2 (en) * | 2004-06-29 | 2006-01-12 | Amgen Inc. | Furanopyrimidines |
WO2007079862A1 (de) * | 2005-12-21 | 2007-07-19 | Bayer Healthcare Ag | Neue, acyclisch substituierte furopyrimidin-derivate und ihre verwendung zur behandlung von kardiovaskulären erkrankungen |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943639A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE10141212A1 (de) | 2001-08-22 | 2003-03-06 | Bayer Ag | Neue 4-Aminofuropyrimidine und ihre Verwendung |
JP4486817B2 (ja) | 2001-12-20 | 2010-06-23 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 1,4−ジヒドロ−1,4−ジフェニルピリジン誘導体 |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
GB0219896D0 (en) | 2002-08-27 | 2002-10-02 | Bayer Ag | Dihydropyridine derivatives |
AU2003293356A1 (en) | 2002-08-27 | 2004-03-19 | Bayer Healthcare Ag | Dihydropyridinone derivatives as hne inhibitors |
EP1546113B1 (de) | 2002-09-10 | 2013-05-01 | Bayer Intellectual Property GmbH | Pyrimidinonderivate als therapeutische mittel gegen aktute und chronische entzündliche, ischämische und verändernde prozesse |
EP1539710B1 (de) | 2002-09-10 | 2010-10-27 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclische derivate |
ATE516285T1 (de) | 2004-02-19 | 2011-07-15 | Bayer Schering Pharma Ag | Dihydropyridinonderivate |
ES2428503T3 (es) | 2004-02-26 | 2013-11-08 | Bayer Intellectual Property Gmbh | 1,4-Diaril-dihidropirimidin-2-onas y su uso como inhibidores de elastasa de neutrófilos humanos |
CA2557271C (en) | 2004-02-26 | 2012-08-21 | Bayer Healthcare Ag | 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors |
-
2007
- 2007-04-26 DE DE102007019691A patent/DE102007019691A1/de not_active Withdrawn
-
2008
- 2008-04-16 WO PCT/EP2008/003007 patent/WO2008131858A2/de active Application Filing
- 2008-04-16 CA CA002685128A patent/CA2685128A1/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1817146A1 (de) * | 1968-01-05 | 1969-11-27 | Pfizer & Co C | 4-Aminofuro[2,3-d]pyrimidine und deren Verwendung als Relaxantien fuer glatte Muskeln |
EP1018514A1 (de) * | 1998-07-22 | 2000-07-12 | Suntory Limited | Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten |
WO2000075145A1 (en) * | 1999-06-03 | 2000-12-14 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
EP1132093A1 (de) * | 1999-09-17 | 2001-09-12 | Suntory Limited | Vorbeugungsmittel oder heilmittel gegen myokarditis, dilatierte kardiomyopathie und herzinsuffiziens, die nf-kappa b inhibitoren als aktiven bestandteil enthalten |
WO2002092603A1 (en) * | 2001-05-14 | 2002-11-21 | Novartis Ag | Oxazolo-and furopyrimidines and their use in medicaments against tumors |
WO2003022852A2 (en) * | 2001-09-11 | 2003-03-20 | Smithkline Beecham Corporation | Furo-and thienopyrimidine derivatives as angiogenesis inhibitors |
WO2005092896A1 (en) * | 2004-03-12 | 2005-10-06 | Korea Institute Of Science And Technology | Compound for inhibiting tyrosine kinase activity of ddr2 protein |
WO2005121149A1 (en) * | 2004-06-10 | 2005-12-22 | Xention Discovery Limited | Furanopyrimidine compounds effective as potassium channel inhibitors |
WO2006004658A2 (en) * | 2004-06-29 | 2006-01-12 | Amgen Inc. | Furanopyrimidines |
WO2007079862A1 (de) * | 2005-12-21 | 2007-07-19 | Bayer Healthcare Ag | Neue, acyclisch substituierte furopyrimidin-derivate und ihre verwendung zur behandlung von kardiovaskulären erkrankungen |
Non-Patent Citations (4)
Title |
---|
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; November 2002 (2002-11-01), GALIÈ NAZZARENO ET AL: "Emerging medical therapies for pulmonary arterial hypertension.", XP002528176, Database accession no. NLM12525997 * |
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; September 2006 (2006-09-01), BRESSER PAUL ET AL: "Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.", XP002528177, Database accession no. NLM16963540 * |
PROCEEDINGS OF THE AMERICAN THORACIC SOCIETY SEP 2006, vol. 3, no. 7, September 2006 (2006-09-01), pages 594 - 600, ISSN: 1546-3222 * |
PROGRESS IN CARDIOVASCULAR DISEASES 2002 NOV-DEC, vol. 45, no. 3, November 2002 (2002-11-01), pages 213 - 224, ISSN: 0033-0620 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008131858A2 (de) | 2008-11-06 |
DE102007019691A1 (de) | 2008-10-30 |
CA2685128A1 (en) | 2008-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010057101A3 (en) | Compounds useful as hiv blockers | |
HK1146485A1 (de) | ||
WO2007058602A3 (en) | Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. | |
NO20091655L (no) | Substituerte dihydropyrazoloner for behandling av kardiovaskulaere og hematologiske sykdommer | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
WO2008079291A3 (en) | Substituted heterocycles and methods of use | |
MX2009012168A (es) | Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta. | |
MY150702A (en) | Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them | |
WO2006106326A8 (en) | Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors | |
WO2008076046A8 (en) | Novel 2-amino-5, 5-diaryl-imidazol-4-ones | |
WO2009145456A3 (ko) | 헤테로사이클 유도체 | |
TW200621765A (en) | Substituted phenylaminothiazoles and their use | |
WO2009026179A3 (en) | Antiinfective proanthocyanidin compounds and methods of use thereof | |
WO2008001195A3 (en) | Novel processes for the preparation of dpp iv inhibitors | |
DOP2006000062A (es) | Derivados de acido pirimidincarboxilico y su uso | |
UA102238C2 (en) | 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof | |
TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
UA95103C2 (ru) | Замещенные арилсульфонамиды в качестве противовирусных средств | |
TW200738651A (en) | Cyclohexyl sulfonamide derivatives | |
WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
WO2009124962A3 (en) | Sulfonamides | |
WO2006023843A3 (en) | Novel heterocycles | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
WO2009003719A3 (en) | Indane-amine derivatives, their preparation and use as medicaments | |
MX2009001315A (es) | Compuestos de dimetilciclobutilo substituidos, su preparación y uso en medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08735262 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008735262 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2685128 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010504501 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |